Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
DexCom (DXCM) PT Raised to $140 at Jefferies
February 10, 2023 8:13 AM ESTJefferies analyst Matthew Taylor raised the price target on DexCom (NASDAQ: DXCM) to $140.00 (from $135.00) while maintaining a Buy rating following earnings.
The analyst commented, "DXCM reported 4Q sales of $815.2MM +20% organic, and reiterated guidance for the year. As a reminder, DXCM... More
DexCom (DXCM) Tops Q4 EPS by 7c
February 9, 2023 4:06 PM ESTDexCom (NASDAQ: DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35 million.
GUIDANCE:
DexCom sees Q1 2023 revenue of $3.35-3.49 billion, versus the consensus of $3.47... More
